Upon intravenous administration in vivo in IBD models, this SOD/CAT-loaded nanocarrier significantly enhanced tissue regeneration and alleviated inflammation, outperforming single enzyme (SOD or CAT)-loaded nanocarriers and free mixtures of both enzymes without the nanocarrier [121]. The gene discussed is SOD1; the disease is irritable bowel syndrome.